NorthCrest Asset Manangement LLC lifted its stake in shares of Citigroup Inc. (NYSE:C – Free Report) by 2.8% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 156,949 shares of the company’s stock after acquiring an additional 4,328 shares during the period. NorthCrest Asset Manangement LLC’s holdings in Citigroup were worth $7,359,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors have also modified their holdings of the stock. Panagora Asset Management Inc. increased its stake in Citigroup by 24.5% during the first quarter. Panagora Asset Management Inc. now owns 29,752 shares of the company’s stock worth $1,589,000 after purchasing an additional 5,853 shares during the period. Zions Bancorporation N.A. grew its position in shares of Citigroup by 50.5% during the first quarter. Zions Bancorporation N.A. now owns 6,256 shares of the company’s stock worth $334,000 after buying an additional 2,100 shares in the last quarter. Brown Brothers Harriman & Co. grew its position in shares of Citigroup by 20.8% during the first quarter. Brown Brothers Harriman & Co. now owns 5,274 shares of the company’s stock worth $282,000 after buying an additional 907 shares in the last quarter. Ergoteles LLC acquired a new position in Citigroup in the first quarter valued at approximately $761,000. Finally, Halbert Hargrove Global Advisors LLC boosted its holdings in Citigroup by 7.0% in the first quarter. Halbert Hargrove Global Advisors LLC now owns 4,077 shares of the company’s stock valued at $218,000 after purchasing an additional 268 shares in the last quarter. Hedge funds and other institutional investors own 69.39% of the company’s stock.
Insider Transactions at Citigroup
In other news, insider Zdenek Turek sold 12,000 shares of Citigroup stock in a transaction on Tuesday, April 18th. The stock was sold at an average price of $49.87, for a total transaction of $598,440.00. Following the completion of the transaction, the insider now owns 155,979 shares of the company’s stock, valued at approximately $7,778,672.73. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 0.09% of the company’s stock.
Analyst Upgrades and Downgrades
Citigroup Price Performance
Citigroup stock opened at $45.74 on Monday. Citigroup Inc. has a 12 month low of $40.01 and a 12 month high of $54.56. The company has a debt-to-equity ratio of 1.48, a current ratio of 0.95 and a quick ratio of 0.95. The business has a 50 day simple moving average of $46.39 and a 200-day simple moving average of $47.71. The stock has a market capitalization of $89.04 billion, a PE ratio of 6.38, a price-to-earnings-growth ratio of 1.75 and a beta of 1.56.
Citigroup (NYSE:C – Free Report) last released its earnings results on Friday, April 14th. The company reported $2.19 EPS for the quarter, beating analysts’ consensus estimates of $1.66 by $0.53. Citigroup had a return on equity of 7.84% and a net margin of 12.96%. The company had revenue of $21.40 billion during the quarter, compared to the consensus estimate of $20.07 billion. During the same quarter last year, the company earned $2.02 earnings per share. Citigroup’s quarterly revenue was up 11.5% compared to the same quarter last year. Equities analysts predict that Citigroup Inc. will post 5.89 earnings per share for the current year.
Citigroup Profile
Citigroup Inc, a diversified financial services holding company, provides various financial products and services to consumers, corporations, governments, and institutions in North America, Latin America, Asia, Europe, the Middle East, and Africa. It operates through three segments: Institutional Clients Group (ICG), Personal Banking and Wealth Management (PBWM), and Legacy Franchises.
Featured Stories
- Five stocks we like better than Citigroup
- Commercial Metals Winning Infrastructure and Datacenter Customers
- Biogen Shares Fall After FDA Approval Of Alzheimer’s Drug Leqembi
- Shell’s Production Outlook: Not as Bad as Expected?
- Tyson Foods Becomes a Value Play, Cyclical Bull Run Coming
- Enphase Energy is Still Converting Solar Energy into Profits
Want to see what other hedge funds are holding C? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Citigroup Inc. (NYSE:C – Free Report).
Receive News & Ratings for Citigroup Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Citigroup and related companies with MarketBeat.com's FREE daily email newsletter.